Printer Friendly

ANNENBERG CENTER AT EISENHOWER HOSPITAL IS HOST SITE FOR PRIMARY NOCTURNAL ENURESIS SYMPOSIUM

 PALM SPRINGS, Calif., Sept. 30 /PRNewswire/ -- Physician experts from across the United States are meeting at a novel medical symposium to develop community outreach programs and treatment centers that will support national efforts to expand the awareness and treatment of Primary Nocturnal Enuresis (PNE), or night-time bedwetting.
 Such an advisory group will allow physicians across the nation to better serve the medical, educational and social needs of patients and their families in dealing with PNE, a condition that affects 5 million to 7 million children between the ages of 6 and 18.
 The members of the advisory panel are meeting for three days (Oct. 1-3), at the Annenberg Center at Eisenhower Hospital in Rancho Mirage, Calif. The meeting will focus on how to develop community outreach programs and establish PNE treatment centers. A series of evening lectures will also discuss how physicians can partner with patients and their families to improve the quality of patient care for bedwetting.
 Rhone-Poulenc Rorer (NYSE: RPR) (RPR) has a history of supporting efforts to promote discussion and knowledge concerning PNE treatment. According to Charles McNally, M.D., group vice-president of Medical Affairs, "Information dissemination is as important as the treatments that are available such as behavior modification, alarm systems and pharmacologic therapy like DDAVP(R) Nasal Spray. We're finding that many cases exist in which positive steps could have been taken earlier had parents known where PNE was treated, as well as how to approach this sensitive subject. One of the treating physician's responsibilities is to increase the likelihood that the discussion can and does take place in their office."
 Since PNE is a disorder which affects 5 million to 7 million children, a great need exists to provide physicians with available information on patient counseling and treatment. Physicians also play an important role in educating their medical staff and parents about PNE. One of the highlights of the three-day conference will be a special "town meeting," which brings together physicians, nurses, parents and children who have shared interests in overcoming many of the problems associated with bedwetting.
 "We believe that experiences discussed at the town meeting will provide physicians with greater insights as to the needs of PNE patients and their families upon return to their home-town practices. Physicians will be initiating educational outreach programs in their own communities to raise awareness, reduce the stigma, and increase the number of treatment successes for PNE," added McNally.
 Parents and treaters of enueretic children can get more information by contacting the National Enuresis Society, at 1-800-NES-8080.
 RPR manufactures and markets DDAVP(R) Nasal Spray, a product indicated for the treatment of PNE.
 Rhone-Poulenc Rorer is a global pharmaceutical company dedicated to the discovery, development, manufacturing and marketing of human pharmaceuticals. The company reported sales of $4.1 billion and invested over $500 million in research and development in 1992.
 /delval/
 -0- 9/30/93
 /CONTACT: Rhone-Poulenc Rorer media relations, 215-454-3871/
 (RPR)


CO: Rhone-Poulenc Rorer ST: Pennsylvania IN: MTC SU:

JM -- PH015 -- 7273 09/30/93 12:19 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 30, 1993
Words:503
Previous Article:BRAVO, PRIME TO HONOR THREE FINALISTSN? CHICAGO 'COMMUNITY CINEMA' COMPETITION, TO BE SCREENED AT CHICAGO INTERNATIONAL FILM FESTIVAL
Next Article:CP&L TO MAKE REPAIRS IN CORE SHROUD
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters